Focus

Neurotech Investors: Angels and VC Firms

The RaiseHunt database lists 73 Neurotech investors: 27 angel investors and 46 people at 24 firms. Most list Seed and Series A among their stages; the largest hubs are San Francisco, Boston and Singapore.

Strongest in San Francisco, Boston and Singapore

Common stages: Seed and Series A

73
Neurotech investors
27
Angel investors
46
People at VC/PE firms
24
Firms tagged

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

73 Neurotech investors

Showing 1-20

Filters
David Fox
David Fox

Mentor

San Francisco, United States
AngelOperator angel
AIConsumer
View profile
Saturnin Pugnet
Saturnin Pugnet

Venture Partner

San Francisco, United States
AngelOperator angel
AIFinTech
View profile
Mark Gorham
Mark Gorham

Program Director - Cleantech

Denver, United States
AcceleratorVenture capital
AIEducation
View profile
Patrick S. Chung
Patrick S. Chung

General Partner

Palo Alto, United States
Venture capital
AICommerce
View profile
Ozi A.
Ozi A.

Venture Capital

Singapore
AcceleratorCorporate VC
AICommerce
View profile
Joy Bhakat
Joy Bhakat

Head of Investments

Mumbai, India
Private equityVenture capital
CommerceConsumer
View profile
Agradeep Mondal
Agradeep Mondal

Managing Director

Bengaluru, India
AcceleratorCorporate VC
AIClimate
View profile
Adam Caplan
Adam Caplan

Founder & GP

New York, United States
AngelOperator angel
AIFinTech
View profile
Bryan Johnson
Bryan Johnson

Founder

Los Angeles, United States
AngelOperator angel
AIConsumer
View profile
Julia Moore
Julia Moore

Managing Partner

San Francisco, United States
Venture capital
AIHardware
View profile
Lindy Morris Fishburne
Lindy Morris Fishburne

Managing Partner

San Francisco, United States
Venture capital
AIHardware
View profile
Nima Ronaghi
Nima Ronaghi

Partner

San Francisco, United States
Venture capital
AIHardware
View profile
Chris Eu
Chris Eu

Investor

Singapore
Venture capital
AIFinTech
View profile
Scott Wharton
Scott Wharton

angel investor and operator angel

Los Altos, United States
AngelOperator angel
ClimateHardware
View profile
Zhiyu Zhang
Zhiyu Zhang

Affiliated

Hong Kong
Venture capitalVenture debt
AIFinTech
View profile
Scott Blumberg
Scott Blumberg

angel investor and operator angel

Los Angeles, United States
AngelOperator angel
Healthcare
View profile
Mark Edwards
Mark Edwards

angel investor and operator angel

New York, United States
AngelOperator angel
AIHardware
View profile
Tim Rosa
Tim Rosa

angel investor and operator angel

Mill Valley, United States
AngelOperator angel
AIConsumer
View profile
Ryan Roddy
Ryan Roddy

Co-Founder & General Partner

Austin, United States
Venture capital
CommerceConsumer
View profile
Michael Fenn
Michael Fenn

Venture Partner

Boston, United States
Venture capital
AIHealthcare
View profile

Frequently asked questions

How many Neurotech investors are on RaiseHunt?

RaiseHunt currently lists 73 Neurotech investors.

Are Neurotech investors angels or funds?

Both. 27 are angel investors putting in their own money, and 46 are people making investment decisions at 24 firms.

Where are most Neurotech investors based?

The largest concentrations are in San Francisco, Boston and Singapore.

What stage do Neurotech investors invest at?

Most list Seed and Series A among the rounds they take part in.

How do I contact Neurotech investors?

Every profile shows whether an email address is on file. The addresses themselves, along with AI matching and outreach, are in the RaiseHunt app.

Is the list of Neurotech investors free to browse?

Yes. The directory and every profile page are free to read. Matching your own startup against them requires an account.

Do Neurotech investors only back Neurotech companies?

No. A focus area is a signal of interest, not a restriction. Investors usually list several, and the useful question is whether their existing portfolio looks like the kind of company you are building.

What do investors look at first?

The team and the problem, in that order, before the product. Early on there is rarely enough traction to argue from numbers alone, so the question they are answering is whether these particular people are likely to work this problem out.

Should I raise from one investor or several?

Several, in almost every case. A single backer concentrates the risk of the round collapsing if that one conversation goes cold, and a group brings more introductions later. Rounds are usually assembled from a lead plus others who follow.

How do I follow up without being annoying?

Follow up with new information rather than a reminder. A short note saying what changed since you last wrote gives the reader a reason to reply, where "just checking in" gives them none. Two or three of those, spaced out, is normal and expected.

What if no Neurotech investor replies?

Usually the list was too short or too loosely matched, not that the company is unfundable. Widen it, tighten who you are writing to, and rewrite the first two lines of the message. Those lines decide whether anything below them gets read.

What is the difference between an angel investor and a VC fund?

An angel invests their own money and can decide alone, which usually makes the process shorter. A fund invests money it raised from other people, so it answers to those backers and normally runs a longer diligence process before it commits. Founders often raise from angels first and bring in a fund once there is more to show.

Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal